TY - CHAP M1 - Book, Section TI - Chapter 73. The Epidemiology of Breast Reconstruction in North America A1 - Alderman, Amy K. A1 - Streu, Rachel A1 - Wilkins, Edwin G. A2 - Kuerer, Henry M. PY - 2010 T2 - Kuerer's Breast Surgical Oncology AB - After years of lobbying by women's health advocates and amidst much fanfare, the 1998 Federal Breast Cancer Reconstruction Law (also referred to as the Women's Health and Cancer Rights Act of 1998, or WHCRA) was signed into law by President Bill Clinton.1 Passage of this legislation marked the culmination of intensive lobbying efforts by breast cancer survivors, clinicians, researchers, and policymakers to ensure coverage of breast reconstruction following mastectomy by health care payers. In the 2 decades prior to the passage of the WHCRA, a growing body of research demonstrated significant psychosocial and quality-of-life benefits for those receiving breast reconstruction.2-4 Largely as a consequence of these studies, provider and patient perceptions evolved away from viewing breast reconstruction as a "cosmetic" procedure. Instead, health care professionals and consumers concluded that the creation of a new breast following mastectomy was a reconstructive operation and, for many women, an important element in breast cancer recovery. Despite changing attitudes, some health care payers had failed to include breast reconstruction among their covered benefits, steadfastly maintaining that these operations were cosmetic in nature. With enactment of the WHCRA, this barrier was removed. The law mandated that health plans include breast and nipple reconstruction as well as contralateral breast symmetry procedures among their benefits afforded to mastectomy patients. SN - PB - The McGraw-Hill Companies CY - New York, NY Y2 - 2024/04/20 UR - accesssurgery.mhmedical.com/content.aspx?aid=6415681 ER -